# Notice of Contract Award - Orexo US, Inc.

Canonical: https://abierto.us/opportunities/bardabaaorexonotice

- Solicitation number: BARDA-BAA-OrexoNotice
- Notice type: Special notice
- Status: Closed. Deadline was September 24, 2025 at 5:00 PM EDT
- Department: Department of Health and Human Services
- Agency: Office of Assistant Secretary for Preparedness and Response
- Contracting office: Barda - Aspr / Daappo / Barda DCMA (75A501)
- NAICS: 541714 Research and Development in Biotechnology (except Nanobiotechnology)
- Product or service code: AN13 Health R&D Services; Health Care Services; Experimental Development
- Place of performance: Morristown, New Jersey
- County: Morris County (FIPS 34027). https://abierto.us/counties/morris-county-nj-34027
- City: Morristown. https://abierto.us/cities/morristown-nj-3448300
- First posted: September 26, 2025
- Last posted: September 26, 2025
- SAM.gov: https://sam.gov/workspace/contract/opp/2f2165fde1f3420891121bb88d554782/view

## Description

Award Notice for Orexo US, Inc. (Contract 75A50125C00010). Clinical development of OX390 (atipamezole) as an ?2 agonist reversal agent for human use to counteract the sedative effects of xylazine, medetomidine, and other ?2 agonists that are increasingly found in combination with IMF.

## Publications

- September 26, 2025: Special notice, due September 24, 2025 at 5:00 PM EDT. Notice 2f2165fde1f3420891121bb88d554782. https://sam.gov/workspace/contract/opp/2f2165fde1f3420891121bb88d554782/view

## Points of contact

- Jonathan Gonzalez, Contracting Officer, Jonathan.Gonzalez@hhs.gov, 2023817248
- Joann Kambaja, Contract Specialist, Joann.Kambaja@hhs.gov, 202-913-5470

---
Source: SAM.gov Contract Opportunities bulk extract. Confirm deadlines on SAM.gov before responding. Cite https://abierto.us/opportunities/bardabaaorexonotice.